Search

In the recent two decades, there has been a tremendous increase in the biosynthesis of nanomaterials employing live organisms, their components, extracts, or biomolecules as catalysts. Algae has been used majorly for commercial and industrial uses such as food, feed, skin care, medicines, and fertilizers, algae are now being explored to synthesize green nanoparticles (NPs). Indeed, algae are a rich source of bioactive substances, are easy to produce, grow quickly, and are scalable, therefore this trend is growing by the day. The natural material from algae works as a capping and stabilizing factor in the conversion of metal compounds to metal, metal oxides, or bimetallic NPs. The NPs generated by algae might be intracellular or extracellular, depending on the area of the NPs. The aim of the present review, the first of its kind, is to provide readers with essential information about the diversity of algal strains exploited in the booming field of nanobiotechnology and to explore the biomedical applications of NPs biosynthesized from algae which include antimicrobial, antioxidant, anticancer and biocompatibility properties. Furthermore, this study examines the rationale for the algal-mediated creation of metal, metal oxide, and bimetallic NPs from a variety of algae, as well as the characterization of algae-mediated nanomaterial synthesis.

Zingiberaceae species are widely in traditional medicine throughout the world. This study evaluates the potential biological applications of phyto-functionalised silver nanoparticles (AgNPs) synthe...

Mucormycosis has become increasingly associated with COVID-19, leading to the use of the term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to factors such as resistance to many antifungals and underlying co-morbidities. India is particularly at risk for this disease due to the large number of patients with COVID-19 carrying comorbidities that predispose them to the development of mucormycosis. Additionally, mucormycosis treatment is complicated due to the atypical symptoms and delayed presentation after the resolution of COVID-19. Since this disease is associated with increased morbidity and mortality, early identification and diagnosis are desirable to initiate a suitable combination of therapies and control the disease. At present, the first-line treatment involves Amphotericin B and surgical debridement. To overcome limitations associated with surgery (invasive, multiple procedures required) and amphotericin B (toxicity, extended duration and limited clinical success), additional therapies can be utilized as adjuncts or alternatives to reduce treatment duration and improve prognosis. This review discusses the challenges associated with treating CAM and the critical aspects for controlling this invasive fungal infection—early diagnosis and initiation of therapy, reversal of risk factors, and adoption of a multipronged treatment strategy. It also details the various therapeutic options (in vitro, in vivo and human case reports) that have been used for the treatment of CAM.

Oats (Avena sativa) is a cereal crop of utmost significance with rich therapeutic and nutritive value. Bioactive substances like tocopherols, phenolic acids, alkylresorcinols, beta-glucan, and avenanthramides present in Avena sativa significantly contribute towards its medicinal action. The current research study aims to assess the antioxidant and anti-cancer efficiency of fermented (FO) and non-fermented (NFO) samples of Avena sativa. In vitro anticancer studies on oats were assessed using colon malignant growth cell lines (HT29) by MTT assay. In vitro studies revealed that fermented and non-fermented oats displayed higher antioxidant activity, having a corresponding IC50 value of 201.03 µL and 236.46 µL, respectively. The cancer cell death percentage at 250 μg/mL concentration ranged between 58.19% and 51.85%, respectively.

Oral Submucous Fibrosis (OSMF) is a chronic debilitating disease more frequently found in the South East Asian population. This disease poses a public health priority, as it is grouped under oral potentially malignant disorders, with malignant transformation rates of around 7 to 13%. Hence, early identification of high-risk OSMF patients is of the utmost importance to prevent malignant transformation. Proteomic expression profiling is a promising method for identifying differentially expressed proteins for disease prognosis and risk stratification in OSMF. In this study, overexpressed proteins in OSMF, OSMF transformed into oral squamous cell carcinoma (OSCC) and normal tissues were evaluated by proteomic analysis using two-dimensional electrophoresis (2DE) and mass spectrometry, which revealed 23 upregulated proteins. Validation was done using immunohistochemistry for three secretory proteins, namely 14-3-3ε (n = 130), carbonic anhydrase 1 (CA 1) (n = 125) and heat shock protein 70 (HSP 70) (n = 117), which showed significant overexpression in OSMF, OSCC compared to normal. The present study is the first of its kind in India to the best of our knowledge, assessing the altered expression of proteins in OSMF and OSMF which has undergone malignant transformation, obtaining a better knowledge of the molecular pathways involved in the disease progression. The current study shows that the biomarkers studied can be potentially useful for risk stratification of OSMF to OSCC serving as novel targets for therapeutic intervention. Clinical validation of the targets can further pave way for precision medicine to improve the quality of life in OSMF patients.